Em. Wheatley et al., INCORPORATION OF FIBRONECTIN INTO MATRIX DECREASES TNF-INDUCED INCREASE IN ENDOTHELIAL MONOLAYER PERMEABILITY, The American journal of physiology, 265(2), 1993, pp. 120000148-120000157
Plasma fibronectin, a dimeric adhesive protein in blood, incorporates
into the subendothelial and interstitial matrix in the lung especially
during vascular injury. Fibronectin in the matrix is believed to infl
uence cell-cell interaction and endothelial cell adhesion to the colla
gen-rich extracellular matrix. We previously observed that addition of
purified soluble human plasma fibronectin (hFn) to cultured pulmonary
endothelial monolayers attenuates the increase in protein permeabilit
y of such monolayers exposed to tumor necrosis factor-alpha (TNF-alpha
). In the current study, we determined the specificity of this permeab
ility response to fibronectin by comparing hFn to two other purified a
dhesive proteins in human plasma, i.e., vitronectin (Vn) and fibrinoge
n (Fg). We also determined whether matrix incorporation was essential
for this hFn-mediated protective response by comparing normal intact h
Fn to either hFn alkylated with N-ethylmaleimide (NEM) or to purified
160/180-kDa hFn fragments, since these alternate forms of fibronectin
are believed to exhibit limited ability to incorporate into matrix. Ca
lf pulmonary artery endothelial (CPAE) monolayers (3-4 days postseedin
g) were exposed to human recombinant TNF-alpha for 18 h at a medium co
ncentration of 200 U/ml followed by assessment of protein permeability
using transendothelial I-125-labeled albumin clearance. Dimeric hFn (
600 ug/ml) significantly (P < 0.05) reduced the TNF-induced increase i
n endothelial monolayer permeability. Vn or Fg, added at equal molar c
oncentrations to the hFn, were unable to attenuate endothelial permeab
ility. Immunofluorescent analysis utilizing antibodies specific to eit
her hFn, human Vn, or human Fg revealed incorporation of the exogenous
hFn into the extracellular matrix, but no matrix incorporation of Vn
or Fg. Both NEM-treated dimeric hFn as well as purified 160/180-kDa fr
agments of hFn, which cannot incorporate into the matrix, were also un
able to prevent the TNF-induced increase in protein permeability. Thus
the ability for soluble hFn to reduce the TNF-induced increase in lun
g endothelial monolayer permeability was specific and dependent on its
incorporation into the extracellular matrix.